News and Alerts

For your convenience, this section includes a summary of this month's important PBS changes.

For the full Schedule of Pharmaceutical Benefits, go to the PBS website at http://www.pbs.gov.au/ where you can search the schedule by drug name.

For Highly Specialised Drugs (HSD) items (CAR and non-CAR), refer to the Schedule of Pharmaceutical Benefits as well as Services Australia to confirm whether the PBS item code for a HSD is eligible to be dispensed and claimed by your pharmacy type.

  • 20 February 2025 See you at APP!

    Come visit the Fred and MedView teams at APP next month to see what’s new in the world of pharmacy IT. Discover new partner integrations and offers. Get hands-on with MedView Digital Baskets. If you’re interested in improving your pharmacy’s efficiency, we’ve got the IT innovations to help.

    Find us on stands 124-127 inside the main exhibition hall.

    Thu 20 Mar5.30pm - 8.30pmWelcome Reception
    Fri 21 Mar9.00am - 6.30pmTrade Exhibition
    Fri 21 Mar5.30pm - 6.30pmWind down at APP’s inaugural ‘Happy Hour' straight after the Conference Sessions conclude
    Sat 22 Mar9.00am - 4.00pmTrade Exhibition

    Digital Health: The next 5 years for pharmacy

    Thursday 20 March | 2.00-2.45pm | Arena 1A

    The May 2023 federal budget revealed a $1.1 billion investment to update the digital health infrastructure and to transform My Health Record into a more data-rich platform. With pharmacists expanding their roles, this session will outline how this digital investment can enhance health outcomes for Australians. It will explore the implications for pharmacists with an upgraded My Health Record, and how the evolving digital medication platforms seek to further improve medication safety.

    Moderator: Paul Naismith - Founder and CEO, Fred IT Group

    Panellists:

    • Daniel McCabe - First Assistant Secretary Medicare Benefits and Digital Health, Australian Government Department of Health

    • Paul Creech - Chief Program Officer, Australian Digital Health Agency

    • Regina Cowie - Partnerships Manager eHealth, Fred IT Group.

     
  • 6 February 2025: Update to Continued Dispensing Arrangements – Emergency Measures

    From 4 February 2025 to 31 March 2025, a temporary PBS Continued Dispensing Emergency Measure has been put in place to support people affected by the flooding disaster in Far North Queensland to continue to access their PBS subsidised medicines.

    This PBS Continued Dispensing Emergency Measure will support access to a wider range of PBS medicines than under ongoing Continued Dispensing arrangements, covering most medicines on the General Schedule of the PBS. For further information, please see the Pharmaceutical Benefits Scheme Continued Dispensing Arrangements webpage.

    The February Fred Dispense Plus drug file has been updated with the expanded list. When dispensing eligible authority items, please remember to use 123 as the authority number and enter ‘A2022CD’ in the phone approval number section.

    For continued dispensing related queries please refer to the link above. If you have any other questions, refer to Dispense a Continued Dispensing Supply or contact Fred Help.

  • 1 February 2025: PBS Changes - February 2025
  • 17 January 2025: Disabling or re-enabling electronic prescriptions

    In the event of potential clinical risks with dispensing and supplying an ePrescription, you are reminded that you can disable an ePrescription in Fred Dispense Plus.

    This is particularly important if the patient is a doctor shopper or you suspect the prescription may be fraudulent.

    For step-by-step instructions, see Disable or re-enable an ePrescription.

  • 6 January 2025: PBS Changes - January 2025
  • 6 January 2025: Fee Changes From 1 January 2025

    Fees are mostly remaining the same except for the General Safety Net Threshold.

    As part of the 8CPA agreement, there will be a 1- year freeze on PBS copayments for General Patients, and up to a 5-year freeze for concession patients.

    Category

    Fees

    2024

    From
    1 January 2025

    Dispensing fees

    Allowable additional
    patient charge

    $3.45

    $3.45

    Patient co-payment

    General

    Concessional

    $31.60

    $7.70

    $31.60

    $7.70

    Safety Net threshold

    General

    Concessional

    $1647.90

    $277.20

    $1694.00

    $277.20

    Copayment discounting will also be phased out with the following discounting rules to take effect from 1 January 2025.

      Category 2024 From
    1 January 2025
    Allowable discount General $1.00 $0.10
    Concessional $1.00 $0.80
  • 6 January 2025: Freeze on PBS patient co-payments and removal of allowable discount

    What is happening?

    Currently both general and concessional PBS co-payments are indexed on 1 January each year, in line with the Consumer Price Index.

    In 2024, the co-payments were $31.60 for general patients and $7.70 for concessional patients.

    From 1 January 2025, the government will introduce:

    • a 1-year freeze on indexation for PBS co-payments for general patients

    • a 5-year freeze on indexation for PBS co-payments for concessional patients.

    Currently, if the total cost of a PBS medicine is above a patient’s co-payment, pharmacists can reduce the co-payment for that patient by applying an allowable discount, up to an amount of $1, for each supply.

    From 1 January 2025, the allowable discount (aka ‘$1 discount’) will be phased out (over 1 or 5 years) while annual increases to the general and concessional PBS co-payments are frozen.

    The discount will decrease by the amount of indexation that would have otherwise applied to the general or concessional patient PBS co-payment, as relevant, until it reaches zero.

    What will this look like for patients?

    • For general patients, the general PBS co-payment for the 2025 calendar year will remain at the level applying in 2024 – that is, a maximum of $31.60 for PBS medicines will be payable.

      From 1 January 2026 onwards, the PBS co-payment will again be annually indexed in line with the Consumer Price Index (CPI).

    • For concessional patients, from 1 January 2025 the concessional PBS co-payment will remain at the level applicable for 2024 for the next five calendar years – that is, a maximum of $7.70 for PBS medicines will be payable.